AbCellera Biologics (ABCL) EBITDA (2020 - 2026)
AbCellera Biologics (ABCL) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM AbCellera Biologics (ABCL) EBITDA is -$192M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
AbCellera Biologics (ABCL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -37.96% |
| 3 Years TTM | +63.49% |
Annual EBITDA change of AbCellera Biologics (ABCL)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$51M | -74.49% |
| 2025 | -$199M | -34.27% |
| 2024 | -$302M | +42.02% |
| 2023 | -$213M | -187.09% |
| 2022 | $244M | +11.65% |
| 2021 | $219M | +36.05% |
| 2020 | $161M | -6509.16% |
| 2019 | -$2.51M | N/A |